RadNet, Inc.
RDNT
Ранг среди акций
#3233
RadNet, Inc. operates as a prominent healthcare services company specializing... RadNet, Inc. operates as a prominent healthcare services company specializing in outpatient diagnostic imaging across the United States. Their comprehensive offerings span a broad spectrum of advanced imaging techniques, including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, and general diagnostic radiology, along with various specialized procedures. Beyond direct patient services, the company also plays a significant role in developing and marketing specialized computerized systems for the diagnostic imaging sector, such as picture archiving communication systems (PACS) and associated support. Furthermore, RadNet is at the forefront of integrating artificial intelligence (AI) solutions, designing and deploying AI suites to augment radiologist interpretation, particularly in mammography, and extending these AI capabilities to lung and prostate cancer diagnostics. As of December 31, 2021, its operational footprint included ownership and management of 347 centers situated across seven states: Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. Established in 1981, the company maintains its headquarters in Los Angeles, California.
Цена акции
$69.77
Последняя синхронизация: 2026-10-20
Рыночная капитализация
$5.49B
Изменение (1 день)
0.72%
Изменение (1 год)
-12.96%
Страна
US
Торговля RadNet, Inc. (RDNT)
Категория
Healthcare
Выручка компании RadNet, Inc. (RDNT)
Выручка на Jun 2026 TTM: $2.27B
Согласно последним финансовым отчетам RadNet, Inc., текущая выручка компании (TTM) составляет $2.27B. В 2023 году компания получила выручку $1.62B больше, чем выручке в 2022 году, которая составила $1.43B. Выручка — это общий доход, который компания получает от продажи товаров или услуг. В отличие от прибыли, расходы не вычитаются.
История выручки RadNet, Inc. с 2000 по 2026
Выручка на конец каждого года
| Год | Выручка | Изменить |
|---|---|---|
| 2026 (TTM) | $2.27B | 24.01% |
| 2024 | $1.83B | 13.18% |
| 2023 | $1.62B | 13.05% |
| 2022 | $1.43B | 8.74% |
| 2021 | $1.32B | 22.69% |
| 2020 | $1.07B | -7.13% |
| 2019 | $1.15B | 18.36% |
| 2018 | $975.15M | 5.74% |
| 2017 | $922.19M | 4.26% |
| 2016 | $884.54M | 9.25% |
| 2015 | $809.63M | 12.83% |
| 2014 | $717.57M | 2.07% |
| 2013 | $702.99M | 8.63% |
| 2012 | $647.15M | 4.41% |
| 2011 | $619.80M | 12.99% |
| 2010 | $548.54M | 4.61% |
| 2009 | $524.37M | 4.43% |
| 2008 | $502.12M | 18.01% |
| 2007 | $425.47M | 164.26% |
| 2006 | $161.01M | 10.60% |
| 2005 | $145.57M | 6.04% |
| 2004 | $137.28M | -2.13% |
| 2003 | $140.26M | 0.70% |
| 2002 | $139.28M | 24.54% |
| 2001 | $111.84M | 27.14% |
| 2000 | $87.96M | 0.00% |
Выручка аналогичных компаний или конкурентов
| Компания | Выручка | Разница в выручке | Страна |
|---|---|---|---|
| $46.34B | 1,942.19% |
US
|
|
| $25.11B | 1,006.56% |
US
|
|
| $2.71B | 19.31% |
US
|
|
| - | - |
CN
|
|
| $7.37B | 224.91% |
US
|
